David Scalzo, DPM
Foot & Ankle Surgery · Duryea, PANPI 1477508000
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 71.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $4,199 and has fallen 96.3% since, to $157 in 2025.
Across 34 payments — averaging $164.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Novus Surgical Consultants$917
- Stryker$247
- Novus Surgical Solutions LLC$199
- Smith+Nephew$157
- Organogenesis Inc.$27
- plus $19 from 1 others
What the payments were for
- Travel & lodging$1,10120%
- Food & beverage$1,22822%
- Education$3,25158%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 17 | $4,015 |
| Novus Surgical Consultants | 4 | $917 |
| Stryker | 2 | $247 |
| Novus Surgical Solutions LLC | 3 | $199 |
| Smith+Nephew | 5 | $157 |
| Organogenesis Inc. | 2 | $27 |
| GRT US Holding, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$152
How this compares
$5,580 in reported general payments places this provider in the 70th percentile of 575 foot & ankle surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 136 | $981 |
| Cephalexin | 56 | $854 |
| Ketoconazole | 22 | $728 |
| Terbinafine Hcl | 19 | $432 |
| Ammonium Lactate | 33 | $416 |
| Ciclopirox | 12 | $386 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $371 |
| Allopurinol | 13 | $198 |
| Amoxicillin | 44 | $139 |
| Doxycycline Hyclate | 23 | $110 |
| Triamcinolone Acetonide | 15 | $104 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $102 |
| Meloxicam | 14 | $80 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $74 |
| Prednisone | 23 | $51 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Duryea
- William DecarboBelle Vernon$3.5M
- David PedowitzBryn Mawr$1.6M
- Noman SiddiquiScranton$1.3M
- Peter MangonePittsburgh$1.1M
- Stephen BrigidoBethlehem$656K
- Guido LaportaDunmore$625K
- Adam TeichmanAllentown$545K
- Thomas RocchioAllentown$524K
- Jason MillerMalvern$501K
- James SferraCranberry Township$451K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.